Oral bisphosphonate osteoporosis drugs, which include such Actonel, Boniva, and Fosamax, could be associated with an approximately twofold increased risk of esophageal cancer.
All in all, osteoporosis is a major health risk for nearly 30 million Americans, in large part because many are clueless about how to prevent it.
As a result, osteoporosis has become yet another boon for the pharmaceutical industry. According to a 2010-2025 Osteoporosis World Market Report, the condition generated pharmaceutical revenues of over $12 billion worldwide in 2009.
A civil jury in Maine has awarded $25m to a woman whose teenage daughter died from...
There is not enough evidence to confirm that Tylenol causes autism but the pain medication should...
At just 13 years old, Kevin Tang is establishing himself in the world of science and...
